in this issue
People & Business :: People/Executives
Nuevolution appoints Berkien as chief business officer
December 9, 2013 | Michael Ravenscroft
Nuevolution (Copenhagen, Denmark), a small molecule lead discovery company, says it has appointed Tom Berkien as chief business officer, effective 1 January. Berkien will lead Nuevolution's commercial and business development efforts. He will also become a member of the executive management committee at Nuevolution, and play a key part in strategy planning, the company says. Berkien was recently acting head of corporate development, mergers and acquisitions, at Takeda Pharmaceuticals (Osaka, Japan), where he was responsible for several acquisitions. Before that...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee